CJC 1295

$ 1,000

Type: GHRH analog peptide
Composition: Modified Growth Hormone–Releasing Hormone (GHRH)
Length: 30 amino acids
Modification: Substitutions that increase stability; some versions include DAC (drug affinity complex) via lysine-linked fatty acid

Certificate of Analysis – CJC 1295

What is CJC 1295?

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the release of endogenous growth hormone (GH). It is primarily researched for its ability to extend the half-life of natural GHRH, leading to sustained GH secretion. CJC-1295 is often categorized as a GHRH analog and is notable for its long-acting properties due to its binding to albumin in the bloodstream via Drug Affinity Complex (DAC) technology.

Mechanism of Action

CJC-1295 binds to receptors in the pituitary gland to stimulate growth hormone release, mimicking the body’s natural GHRH. Its DAC component allows it to remain active in circulation for up to a week, providing a prolonged stimulus for GH release. Increased GH levels in research settings have been associated with enhanced protein synthesis, improved recovery, cellular repair, and metabolic regulation.

Solely for laboratory research purposes only. Not intended for human consumption.

Safety Profile

In animal studies and limited clinical trials, CJC-1295 has demonstrated a favorable safety profile, with few adverse effects noted. Potential concerns in research have included transient flushing, headaches, or localized irritation at the injection site. However, long-term data are sparse, and the compound remains investigational and is not approved for therapeutic use.

Solely for laboratory research purposes only. Not intended for human consumption.

Key Studies

A notable clinical trial published in The Journal of Clinical Endocrinology & Metabolism demonstrated that CJC-1295 could significantly increase plasma GH and IGF-1 levels for up to 6 days following a single dose.
Further rodent and primate studies have investigated its effect on lean muscle mass, fat metabolism, and wound healing, confirming its GH-elevating properties.

Solely for laboratory research purposes only. Not intended for human consumption.

Conclusion

CJC-1295 is a valuable research compound for exploring the long-term effects of sustained growth hormone stimulation. Its long half-life and biologically stable profile make it a preferred choice for laboratories studying growth hormone regulation, metabolic enhancement, and tissue regeneration. This compound is for research use only and is not intended for human consumption or therapeutic application.

Solely for laboratory research purposes only. Not intended for human consumption.